Pharmacy’s Penicillin Manufacturing Problems Relate to Recently-Released Guidance Document

By Alexander Gaffney, RF News Editor 

Guidance documents, as the US Food and Drug Administration (FDA) often reminds industry, are not legally binding entities. Rather, they represent insight into regulators’ current best thinking on a particular subject, giving companies the opportunity to make compliant their operations and avoid any regulatory headaches.

 

Pharmacy’s Penicillin Manufacturing Problems Relate to Recently-Released Guidance Document.

Advertisement

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s